Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

/PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today...

Related Keywords

,Company Fourth ,Nasdaq ,Curis Inc ,Compensation Committee ,Fourth Amended ,Incentive Plan ,Curis ,Nc ,